The HIV-1 envelope (Env) glycoprotein is the sole HIV-1 surface protein recognized by the humoral antibody response. A current goal of vaccine design is to elicit broadly neutralizing antibodies (bNAbs) against many variants of the HIV-1 Env. Because bNAbs take a long time to develop and have properties that prevent their elicitation, a design strategy involves triggering the development ofbNAb precursors by vaccination, followed by vaccine boosts to drive an antibody lineage to breadth. Here we describe the structural analysis of an early intermediate (IA4) of the DH270.6 bNAb lineage, a lineage that recognizes the Env V3-loop glycan supersite which includes the N332 glycan and whose bNAb was isolated from blood samples of an HIV-1 infecte...
SummaryA highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The hi...
Thesis (Ph.D.)--University of Washington, 2016-03HIV-1 establishes persistent infection in part due ...
Broadly neutralizing antibodies (bNAbs) to HIV-1 envelope glycoprotein (Env) can prevent infection i...
HIV-1 vaccine design is informed by structural studies elucidating mechanisms by which broadly neutr...
Vaccine design efforts against the human immunodeficiency virus (HIV)have been greatly stimulated by...
Broadly neutralizing antibodies (bNAbs) isolated from HIV-1-infected individuals inform HIV-1 vaccin...
Broadly neutralizing antibodies (bNAbs) isolated from HIV-1-infected individuals inform HIV-1 vaccin...
A highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The high dens...
Worldwide, over 37 million people are currently infected with rapidly mutating human immunodeficienc...
Broadly neutralizing antibodies (bNAbs) isolated from HIV-1 infected individuals inform vaccine desi...
The HIV-1 envelope glycoprotein (Env) is the sole target for HIV broadly neutralizing antibodies (bn...
Summary: Recognition of N-linked glycan at residue N276 (glycan276) at the periphery of the CD4-bind...
A highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The high dens...
Summary: Broadly neutralizing antibodies (bnAbs) targeting the HIV envelope glycoprotein (Env) typic...
SummaryThe HIV envelope glycoprotein (Env) is densely covered with self-glycans that should help shi...
SummaryA highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The hi...
Thesis (Ph.D.)--University of Washington, 2016-03HIV-1 establishes persistent infection in part due ...
Broadly neutralizing antibodies (bNAbs) to HIV-1 envelope glycoprotein (Env) can prevent infection i...
HIV-1 vaccine design is informed by structural studies elucidating mechanisms by which broadly neutr...
Vaccine design efforts against the human immunodeficiency virus (HIV)have been greatly stimulated by...
Broadly neutralizing antibodies (bNAbs) isolated from HIV-1-infected individuals inform HIV-1 vaccin...
Broadly neutralizing antibodies (bNAbs) isolated from HIV-1-infected individuals inform HIV-1 vaccin...
A highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The high dens...
Worldwide, over 37 million people are currently infected with rapidly mutating human immunodeficienc...
Broadly neutralizing antibodies (bNAbs) isolated from HIV-1 infected individuals inform vaccine desi...
The HIV-1 envelope glycoprotein (Env) is the sole target for HIV broadly neutralizing antibodies (bn...
Summary: Recognition of N-linked glycan at residue N276 (glycan276) at the periphery of the CD4-bind...
A highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The high dens...
Summary: Broadly neutralizing antibodies (bnAbs) targeting the HIV envelope glycoprotein (Env) typic...
SummaryThe HIV envelope glycoprotein (Env) is densely covered with self-glycans that should help shi...
SummaryA highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The hi...
Thesis (Ph.D.)--University of Washington, 2016-03HIV-1 establishes persistent infection in part due ...
Broadly neutralizing antibodies (bNAbs) to HIV-1 envelope glycoprotein (Env) can prevent infection i...